knowledge -WSS

knowledge

author：knowledge 2025-09-27 22:50:03 - browse：63147

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Readout Newsletter: The latest at Gilead, Catalent, and the NIH

knowledge

WSS

Teladoc has a new CEO, but challenges remain the same

Weight loss drug costs may need more research, senator suggests

Surge of respiratory disease in China has likely explanation

Study: Why relieving medical debt did not improve financial outcomes

Wegovy, Zepbound and weight loss drugs that preserve muscle

David Sabatini, ex

leisure time

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Sports medicine is finally prioritizing gender equality

Surge of respiratory disease in China has likely explanation

Moonlake's readout produced a cash windfall. Risks remain

U.K. considers world's first use of meningitis vaccine to address gonorrhea

ChatGPT in medicine: STAT answers readers' burning questions

NYU radiologists take on the challenge of expensive MRI machines

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

My daughter's legacy lives on through her writing, phage therapy

The cancer drug shortage isn’t new — and neither are the solutions

A daunting task: navigating dual Medicare, Medicaid eligibility

explore

In key trial, Verve's treatment lowers cholesterol levels in patients

NIH tests clinical research in primary care with $30 million program

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

World's first CRISPR

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Cigna wins case to block Amy Bricker's move to CVS

knowledge

hotspot

knowledge

knowledge